How do you treat patients with small cell lung cancer that is primarily refractory to platinum/etoposide (i.e. disease that continues to progress despite first-line chemotherapy?)  

For fit patients, what regimen do you prefer outside of a clinical trial?



Answer from: Medical Oncologist at Academic Institution